Literature DB >> 19131590

T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice.

Olga Ovchinnikova1, Anna-Karin L Robertson, Dick Wågsäter, Eduardo J Folco, Marjo Hyry, Johanna Myllyharju, Per Eriksson, Peter Libby, Göran K Hansson.   

Abstract

Rupture of the collagenous, fibrous cap of an atherosclerotic plaque commonly causes thrombosis. Activated immune cells can secrete mediators that jeopardize the integrity of the fibrous cap. This study aimed to determine the relationship between T-cell-mediated inflammation and collagen turnover in a mouse model of experimental atherosclerosis. Both Apoe(-/-) x CD4dnTbetaRII mice with defective transforming growth factor-beta receptors in T cells (and hence released from tonic suppression of T-cell activation) and lesion size-matched Apoe(-/-) mice were used. Picrosirius red staining showed a lower content of thick mature collagen fibers in lesions of Apoe(-/-) x CD4dnTbetaRII mice, although both groups had similar levels of procollagen type I or III mRNA and total collagen content in lesions. Analysis of both gene expression and protein content showed a significant decrease of lysyl oxidase, the extracellular enzyme needed for collagen cross-linking, in aortas of Apoe(-/-)--CD4dnTbetaRII mice. T-cell-driven inflammation provoked a selective and limited increase in the expression of proteinases that catabolize the extracellular matrix. Atheromata of Apoe(-/-)--CD4dnTbetaRII mice had increased levels of matrix metalloproteinase-13 and cathepsin S mRNAs and of the active form of cathepsin S protein but no increase was detected in collagen fragmentation. Our results suggest that exaggerated T-cell-driven inflammation limits collagen maturation in the atherosclerotic plaque while having little effect on collagen degradation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131590      PMCID: PMC2630576          DOI: 10.2353/ajpath.2009.080561

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

Review 1.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

Review 2.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

3.  TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages.

Authors:  P Sarén; H G Welgus; P T Kovanen
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

Review 4.  Coronary plaque disruption.

Authors:  E Falk; P K Shah; V Fuster
Journal:  Circulation       Date:  1995-08-01       Impact factor: 29.690

5.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.

Authors:  S Gupta; A M Pablo; X c Jiang; N Wang; A R Tall; C Schindler
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

6.  Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques.

Authors:  G K Sukhova; U Schönbeck; E Rabkin; F J Schoen; A R Poole; R C Billinghurst; P Libby
Journal:  Circulation       Date:  1999-05-18       Impact factor: 29.690

7.  Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques.

Authors:  Jun-O Deguchi; Elena Aikawa; Peter Libby; Jeffrey R Vachon; Masaki Inada; Stephen M Krane; Peter Whittaker; Masanori Aikawa
Journal:  Circulation       Date:  2005-10-17       Impact factor: 29.690

8.  Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.

Authors:  G K Sukhova; G P Shi; D I Simon; H A Chapman; P Libby
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

9.  Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.

Authors:  Giuseppina Caligiuri; Mats Rudling; Véronique Ollivier; Marie-Paule Jacob; Jean-Baptiste Michel; Göran K Hansson; Antonino Nicoletti
Journal:  Mol Med       Date:  2003 Jan-Feb       Impact factor: 6.354

Review 10.  Collagens, modifying enzymes and their mutations in humans, flies and worms.

Authors:  Johanna Myllyharju; Kari I Kivirikko
Journal:  Trends Genet       Date:  2004-01       Impact factor: 11.639

View more
  21 in total

1.  Transforming growth factor-β: transforming plaque to stability.

Authors:  Kevin Tse; Klaus Ley
Journal:  Eur Heart J       Date:  2012-07-26       Impact factor: 29.983

Review 2.  Calcific aortic valve stenosis: methods, models, and mechanisms.

Authors:  Jordan D Miller; Robert M Weiss; Donald D Heistad
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

3.  Genetical genomics of Th1 and Th2 immune response in a baboon model of atherosclerosis risk factors.

Authors:  A Vinson; J E Curran; M P Johnson; T D Dyer; E K Moses; J Blangero; L A Cox; J Rogers; L M Havill; J L Vandeberg; M C Mahaney
Journal:  Atherosclerosis       Date:  2011-06-17       Impact factor: 5.162

4.  Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis.

Authors:  Dirk Lievens; Kim L Habets; Anna-Karin Robertson; Yasmina Laouar; Holger Winkels; Timo Rademakers; Linda Beckers; Erwin Wijnands; Louis Boon; Munir Mosaheb; Hafid Ait-Oufella; Ziad Mallat; Richard A Flavell; Mats Rudling; Christoph J Binder; Norbert Gerdes; Erik A L Biessen; Christian Weber; Mat J A P Daemen; Johan Kuiper; Esther Lutgens
Journal:  Eur Heart J       Date:  2012-05-21       Impact factor: 29.983

Review 5.  Linking immunity to atherosclerosis: implications for vascular pharmacology--a tribute to Göran K. Hansson.

Authors:  Yong-Jian Geng; Lena Jonasson
Journal:  Vascul Pharmacol       Date:  2011-11-20       Impact factor: 5.773

6.  Differential Roles of Endothelial Cell-Derived and Smooth Muscle Cell-Derived Fibronectin Containing Extra Domain A in Early and Late Atherosclerosis.

Authors:  Prakash Doddapattar; Rishabh Dev; Manish Jain; Nirav Dhanesha; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-21       Impact factor: 8.311

7.  Coronary Artery Remodeling and Fibrosis With Continuous-Flow Left Ventricular Assist Device Support.

Authors:  Amrut V Ambardekar; Mary C M Weiser-Evans; Marcella Li; Suneet N Purohit; Muhammad Aftab; T Brett Reece; Karen S Moulton
Journal:  Circ Heart Fail       Date:  2018-05       Impact factor: 8.790

8.  Insulin-like growth factor-1 increases synthesis of collagen type I via induction of the mRNA-binding protein LARP6 expression and binding to the 5' stem-loop of COL1a1 and COL1a2 mRNA.

Authors:  Christopher D Blackstock; Yusuke Higashi; Sergiy Sukhanov; Shaw-Yung Shai; Branko Stefanovic; A Michael Tabony; Tadashi Yoshida; Patrice Delafontaine
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

Review 9.  Innate and adaptive immunity in atherosclerosis.

Authors:  René R S Packard; Andrew H Lichtman; Peter Libby
Journal:  Semin Immunopathol       Date:  2009-05-16       Impact factor: 9.623

Review 10.  Adaptive immunity and atherosclerosis: mouse tales in the AJP.

Authors:  Andrew H Lichtman
Journal:  Am J Pathol       Date:  2012-11-16       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.